Inhibitors of cyclooxygenase-2 (COX-2) suppressed the proliferation and differentiation of human leukaemia cell lines

被引:62
|
作者
Nakanishi, Y [1 ]
Kamijo, R [1 ]
Takizawa, K [1 ]
Hatori, M [1 ]
Nagumo, M [1 ]
机构
[1] Showa Univ, Sch Dent, Dept Oral & Maxillofacial Surg 2, Ota Ku, Tokyo 1458515, Japan
关键词
U-937; ML-1; COX-2; inhibitor; NS-398; nabumetone; proliferation; differentiation; G0/G1; arrest;
D O I
10.1016/S0959-8049(01)00160-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Prostaglandins (PG) are known to play important roles in the proliferation and differentiation of leukaemia cells. The effect of the inhibitors of cyclooxygenase-2 (COX-2), a rate-limiting enzyme for the synthesis of PG, on the proliferation and differentiation of leukaemia cell lines was investigated. COX-2 inhibitors, NS-398 and nabumetone, suppressed the proliferation of U-937 and ML-1 cells by inducing a G0/G1 cell-cycle arrest. Cell-cycle arrest induced by these COX-2 inhibitors was not associated with an upregulation of the cyclin-dependent kinase inhibitors. COX-2 inhibitors also inhibited the differentiation of these cells induced by interferon-gamma (IFN-gamma), tumour necrosis factor-alpha (TNF-alpha) and retinoic acid (RA). Treatment with NS-398 did not suppress the levels of PGs produced by these cells. Although COX-2 antisense oligonucleotide showed a similar inhibitory effect on these cells, its inhibitory effect was smaller than that of NS-398, These results suggest that COX-2 inhibitors may suppress the proliferation and differentiation of leukaemia cells both via COX-2-dependent and -independent pathways. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1570 / 1578
页数:9
相关论文
共 50 条
  • [41] Cyclooxygenase-2 (COX-2) enzyme inhibitors as potential enhancers of tumor radioresponse
    Milas, L
    SEMINARS IN RADIATION ONCOLOGY, 2001, 11 (04) : 290 - 299
  • [42] Rationale and prospects for the use of cyclooxygenase-2 (COX-2) inhibitors in colorectal cancer
    Buecher, B
    Heymann, MF
    Blottière, HM
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2001, 25 (11): : 967 - 978
  • [43] Expression of cyclooxygenase-2 (COX-2) mRNA in human colorectal adenomas
    Hasegawa, K
    Ichikawa, W
    Fujita, T
    Ohno, R
    Okusa, T
    Yoshinaga, K
    Sugihara, K
    EUROPEAN JOURNAL OF CANCER, 2001, 37 (12) : 1469 - 1474
  • [44] Cellular mitogenesis is inhibited by selective cyclooxygenase-2 (COX-2) inhibitors.
    Longo, W
    Erickson, B
    Mazuski, J
    Panesar, N
    Deshpande, Y
    Kaminski, D
    GASTROENTEROLOGY, 1998, 114 (04) : A636 - A636
  • [45] Cyclooxygenase-2: where are we in 2003? Cardiovascular risk and COX-2 inhibitors
    Mukherjee, D
    Topol, EJ
    ARTHRITIS RESEARCH & THERAPY, 2003, 5 (01) : 8 - 11
  • [46] Comparative molecular field analysis of selective cyclooxygenase-2 (COX-2) inhibitors
    Marot, C
    Chavatte, P
    Lesieur, D
    QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS, 2000, 19 (02): : 127 - 134
  • [47] A DISCUSSION ON CHEMOPREVENTION OF ORAL CANCER BY SELECTIVE CYCLOOXYGENASE-2 (COX-2) INHIBITORS
    Singh, A. K.
    Pandey, A.
    Tewari, M.
    Prakash, Kumar
    Shukla, H. S.
    Pandey, H. P.
    DIGEST JOURNAL OF NANOMATERIALS AND BIOSTRUCTURES, 2010, 5 (02) : 285 - 295
  • [48] Cyclooxygenase-2 (COX-2) inhibitors: future therapeutic strategies for epilepsy management
    Rawat, Chitra
    Kukal, Samiksha
    Dahiya, Ujjwal Ranjan
    Kukreti, Ritushree
    JOURNAL OF NEUROINFLAMMATION, 2019, 16 (01) : 197
  • [49] Fimbristylis aestivalis Vahl: a potential source of cyclooxygenase-2 (COX-2) inhibitors
    Saduddin Talukder
    Khondoker Shahin Ahmed
    Hemayet Hossain
    Tarek Hasan
    Israt Jahan Liya
    Muhammed Amanat
    Nurun Nahar
    Md. Sadikur Rahman Shuvo
    A. F. M. Shahid Ud Daula
    Inflammopharmacology, 2022, 30 : 2301 - 2315
  • [50] Cyclooxygenase-2 (COX-2) is upregulated in human acute corneal inflammation
    Tu, EY
    Khan, NK
    Trajkovic, D
    Harmon, JM
    Koki, AT
    Duffy, M
    McMahon, T
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U1 - U1